Ocular manifestations in SARS-CoV-2 positive patients: a systematic review

References

• World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 124. 2020 [cited 2020 May 24]. World Health Organization. https://apps.who.int/iris/handle/10665/332229
   Google Scholar
• Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28:391–395.
   PubMed Web of Science ®Google Scholar
• Loon S, Teoh B, Oon LL, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88:861–863.
   PubMed Web of Science ®Google Scholar
• Abdul-Rasool S, Fielding BC. Understanding human coronavirus HCoV-NL63~!2009-11-13~!2010-04-09~!2010-05-25~! Open Virol J. 2010;4:76–84.
   PubMedGoogle Scholar
• Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev. 2013;77:144–156.
   PubMed Web of Science ®Google Scholar
• Hong N, Yu W, Xia J, et al. Evaluation of ocular symptoms and tropism of SARS‐CoV‐2 in patients confirmed with COVID‐19. Acta Ophthalmol. 2020;98. DOI:10.1111/aos.14445.
   Web of Science ®Google Scholar
• Aiello F, Gallo Afflitto G, Mancino R, et al. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review. Eye (Lond). 2020;1–6. DOI:10.1038/s41433-020-0926-9.
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Methodological Resources. Systematic review and literature review software by evidence partners. n.d. [cited 2020 May 20]. https://www.evidencepartners.com/resources/methodological-resources/
   Google Scholar
• Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55:e125-e129.
   PubMed Web of Science ®Google Scholar
• Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020;173:242–243.
   PubMed Web of Science ®Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720.
   PubMed Web of Science ®Google Scholar
• Salducci M, La Torre G. COVID-19 emergency in the cruise’s ship: a case report of conjunctivitis. Clin Ter. 2020;171:e189–91.
   PubMed Web of Science ®Google Scholar
• Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020:138. DOI:10.1001/jamaophthalmol.2020.1291.
   Web of Science ®Google Scholar
• Zhang X, Chen X, Chen L, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18:360–362.
   PubMed Web of Science ®Google Scholar
• Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92:589–594.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zeng Y, Tong Y, et al. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. 2020. DOI: 10.1101/2020.02.11.20021956.
   Google Scholar
• Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID‐19 in Wuhan, China: a cross‐sectional study. Acta Ophthalmol. 2020;aos.14472. DOI:10.1111/aos.14472.
   Web of Science ®Google Scholar
• Zhou Y, Duan C, Zeng Y, et al. Ocular Findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127:982–983.
   Web of Science ®Google Scholar
• Deng C, Yang Y, Chen H, et al. Ocular dectection of SARS-CoV-2 in 114 cases of COVID-19 pneumonia in Wuhan, China: an observational study. SSRN Electron J. 2020. DOI:10.2139/ssrn.3543587.
   Google Scholar
• Ma D, Chen C-B, Jhanji V, et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond). 2020:1–8. DOI:10.1038/s41433-020-0939-4.
   Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.
   PubMed Web of Science ®Google Scholar
• Qi J, Zhou Y, Hua J, et al. The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. BioRxiv. 2020. 2020.04.16.045690. DOI:10.1101/2020.04.16.045690.
   PubMedGoogle Scholar
• Choudhary R, Kapoor MS, Singh A, et al. Therapeutic targets of renin-angiotensin system in ocular disorders. J Curr Ophthalmol. 2017;29:7–16.
   PubMed Web of Science ®Google Scholar
• Pichi PNF. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights. Int Ophthalmol. 2020;40(5):1057–1060. DOI:10.1007/s10792-020-01389-2.
   Web of Science ®Google Scholar
• El Otmani H, El Moutawakil B, Rafai MA, et al. Covid-19 and Guillain-Barré syndrome: more than a coincidence! Rev Neurol (Paris). 2020;176:518–519.
   PubMed Web of Science ®Google Scholar
• Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767–783.
   Web of Science ®Google Scholar
• Kahloun R, Abroug N, Ksiaa I, et al. Infectious optic neuropathies: A clinical update. Eye Brain. 2015;7:59–81.
   PubMed Web of Science ®Google Scholar
• Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104. DOI:10.1136/bjophthalmol-2020-316304.
   PubMed Web of Science ®Google Scholar
• Pyrc K, Berkhout B, van der Hoek L. The novel human coronaviruses NL63 and HKU1. J Virol. 2007;81:3051–3057.
   PubMed Web of Science ®Google Scholar
• Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, et al. Clinical features of the first cases and a cluster of coronavirus disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Travel Med Infect Dis. 2020;35:101653.
   Web of Science ®Google Scholar
• Meselson M. Droplets and aerosols in the transmission of SARS-CoV-2. N Engl J Med. 2020;382:2063.
   PubMed Web of Science ®Google Scholar
• Skevaki CL, Galani IE, Pararas MV, et al. Treatment of viral conjunctivitis with antiviral drugs. Drugs. 2011;71:331–347.
   PubMed Web of Science ®Google Scholar